Cambridge Biomedical is positioned to provide support throughout the drug development process, from preclinical through phase IV trials and post-market commercial testing. We are established experts in complex and custom biomarker assay development, assay validation, and specimen analysis.
Our integrated product development services help biopharmaceutical companies shorten time to market, manage risk and access new global markets to maximize portfolio value.
Shantani's portfolio of services based on chemical-proteomics technologies helps you identify & validate drug targets; thus de-risking molecules and supporting crucial GO / NO-GO decisions throughout the drug discovery process.
Czech Republic (1)
United States (1)
Companies See All